A phase I study of ONO-4538(ONO-4538-67)
Phase 1
Completed
- Conditions
- Malignancies (Gastric Cancer/Non-Small Cell Lung Cancer)
- Registration Number
- JPRN-jRCT2080223839
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
2. Eligible for surgical resection with curative intent
3. Pathologically confirmed diagnosis of primary NSCLC or Gastric adenocarcinoma
Exclusion Criteria
1. Advanced or metastatic malignancies
2. Multiple cancer
3. Complication or history of severe hypersensitivity reactions to antibodies and any other drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method